A very complex, but thought-provoking & necessary #TumorBoardTuesday
What happens when you have a patient on biologic therapy for an autoimmune disease/#IBD & they need #BreastCancer treatment?

Weigh in!

36yo 👩🏻‍🦱 self palpates a R breast mass.
PMH: Crohn’s disease - dx 34yo, perianal fistula w/abscess, achieving remission with infliximab/AZA.
🧪Workup: T2N1 TNBC germline neg

🤨What option would you consider?

@MPishvaian @JohnEbbenMDPhD
@breastcancernow @breastcancer @tumorboard

Chemo+IO neoadj➕IO adj ​​
0%
Chemo+IO neoadj ❌IO adj
100%
Chemo❌ IO neoadj/adj
0%
🤷‍♀️ more info needed
0%
Poll ended at .

🌻We’re preparing #TumorBoardTuesday!

🧑‍🔬Join Dr Maryam Lustberg & Dr Adriana Kahn 08.01.23 8pm ET, for a walk through TNBC tx while pt on IS for #Crohns

🌻Don’t miss this essential MDT chat!

🧠Grab FREE #CME credits
👉🏽Visit integrityce.com/TBT2023 for more info

@JohnEbbenMDPhD @MPishvaian #OncoDon #PrecisionMedicine #Oncology #IBD #PrecisionOncology #BreastCancer #Cancer

🔥 #TumorBoardTuesday is a must-attend!

🧑‍🔬Join @marklewismd @CatherineaOC 07.25.23 8pm ET as they explore differentiating midgut & #PNETs

🔥Be part of an insightful discussion!

🧠Get FREE #CME credits as we finalize the case
👉🏽Visit integrityce.com/TBT2023 for more info #OncoDon #GastroDon

#PrecisionMedicine #Oncology #Pancreas #NETs
#NeuroendocrineTumor @MPishvaian @JohnEbbenMDPhD @EmpoweringPts9 @tumorboard @tumor

It's ALMOST time for the #TumorBoardTuesday case wrap up. We apologize for the delay, but promise it will be worth it!

Check back Saturday for our exclusive interview w @RachelRiechelm2 as we talk implications of hypermutation in #NET- don't miss it! https://twitter.com/i/web/status/1654634595868987394

#TumorBoardTuesday on Twitter

“It's ALMOST time for the #TumorBoardTuesday case wrap up. We apologize for the delay, but promise it will be worth it! Check back Saturday for our exclusive interview w @RachelRiechelm2 as we talk implications of hypermutation in #NET- don't miss it!”

Twitter

Thank you to @jessrzanotti & @RachelRiechelm2 for an exceptional #TumorBoardTuesday on hypermutation in #NET- how might this change care in the future?

Check out thread below & answer the question at the end to get free #CME!

Special edition of Case Wrap Up drops tomorrow!💡
---
RT @jessrzanotti
@TumorBoardTues @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD @PamelaKunzMD @marklewismd @DianeReidyLagun @timpawlik @CanHealeu @duiliorocha_…
https://twitter.com/jessrzanotti/status/1653555761094557697

Jéssica Zanotti on Twitter

“@TumorBoardTues @RachelRiechelm2 @MPishvaian @JohnEbbenMDPhD @PamelaKunzMD @marklewismd @DianeReidyLagun @timpawlik @CanHealeu @duiliorocha_onc @RenataDAlpino @DBulzico @Juanmaoconnor @Nanodioca @OncoThor @helops79 @rcarvalhoonco @donadio_ds @leogilsan @ManikAmin4 @chirayumohin @carlacav @realbowtiedoc @jaypsv @viniciu_antonio @letswinpc 6/15 #TumorBoardTuesday 👩🏻‍🏫Mini tweetorial 2👩🏻‍🏫 📌MSI biomarker 📍≤ 10% of neuroendocrine carcinoma 📍MSI & TMB-h rare in G3 (<1%) 📍Hypermutation may be induced by temozolamide in #gliomas and #NETCancer 📍Molecular profiling upon DP on alkylating agents may find TMB-h”

Twitter

📢 Join our 🇧🇷 Brazilian-led #TumorBoardTuesday!!

🥼@RachelRiechelm2 @jessrzanotti teach us treating hypermutation induced in NET #PancreaticCancer
👇🏽

📱Weigh in
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻‍⚕️tag peers
@MPishvaian @JohnEbbenMDPhD
#MedTwitter #WomenInOncology
---
RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass …
https://twitter.com/jessrzanotti/status/1653549758072471553

Jéssica Zanotti on Twitter

“@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter 46yo 👩🏻 asymptomatic no comorb 🌀Screening abd US: liver nodules + pancreatic mass (body/tail) 🔬Liver bx + NET G2 Ki67 12% 🩻PET-Ga + uptake in pancreas & liver (SUVs>20) 💉1L: Lanreotide SC - DP liver after 1y (⬆️volume) 🤨What 2L tx?”

Twitter

🦓1 hour until TONIGHT'S #TumorBoardTuesday!!

🇧🇷@RachelRiechelm2 @jessrzanotti take us through treatment of hypermutation induced by alkylating agent in #PanCan

🦓Finish dinner, grab a drink, and prepare your 🧠 with these #CME

👇🏽See you soon!

---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest Q1⃣
Free #CME🔗http://integrityce.com/TBT2023

📣B4 @RachelRiechelm2 @jessrzanotti teach us hypermutation #NETCancer test your🧠

🤔Which 2L fo…
https://twitter.com/TumorBoardTues/status/1653449001700556816

Tumor Board Tuesday 2023 - Integrity CE

Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.

Integrity CE

🇧🇷 Be sure to join #TumorBoardTuesday 05/02 at 8pm! #PanCan #NETCancer

@PreetpaulS @JaydiDelRivero @TClancyMD @LMFendo @ShaalanBeg @HealingNET1 @laylaPLANETSCh1 @DrMohidKhan @ShalabyK @jgong15 @drjasonstarr @NVijayvergiaMD @jhatjhmi1 @GillSharlene @nanudasmd @DrSukeshiArora… https://twitter.com/i/web/status/1653106342792396800

#TumorBoardTuesday on Twitter

“🇧🇷 Be sure to join #TumorBoardTuesday 05/02 at 8pm! #PanCan #NETCancer @PreetpaulS @JaydiDelRivero @TClancyMD @LMFendo @ShaalanBeg @HealingNET1 @laylaPLANETSCh1 @DrMohidKhan @ShalabyK @jgong15 @drjasonstarr @NVijayvergiaMD @jhatjhmi1 @GillSharlene @nanudasmd @DrSukeshiArora…”

Twitter

#TumorBoardTuesday
😀I am particularly excited to hear about this #PNET case presented by @RachelRiechelm2 & @jessrzanotti

Join us📆Tuesday, May 2nd at🕖8PM ET/9PM BRT for a spirited discussion

#TumorBoardTuesday

And to help us guide the discussion tell us your connection to🩺cases like these👇